DOCSLIB.ORG

A Low Priming Volume Oxygenator for Bloodless Priming in Cardiopulmonary Bypass

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
A Low Priming Volume Oxygenator for Bloodless Priming in Cardiopulmonary Bypass Thorax: first published as 10.1136/thx.20.6.540 on 1 November 1965. Downloaded from Thorax (1965), 20, 540. A low priming volume oxygenator for bloodless priming in cardiopulmonary bypass E. PROCTOR AND A. H. DE BONO' From tl/e Thoracic Research Department, Guy's Hospital, London The oxygenator described here arose out of the need to dispense with homologous blood in animal perfusions. It was considered that this could best be attained with an oxygenator having a priming volume sufficiently small to allow the use of isotonic solutions without undue dilution and consistent with full gas exchange and adequate temperature control. It was recognized that modifications to existing machines were unlikely to reduce the priming volume sufficiently to allow of total haemodilution without a significant reduction in their perform- ance. As a result the following design was evolved (Figs I and 2). copyright. An annular bubble column was devised as the most practical method of attaining efficient gas exchange with a small amount of blood. The annulus increases 'lift' and mixing in the vertical tube and allows of full oxygenation at flows of up to 2 5 1./min. (in the small model shown here) http://thorax.bmj.com/ at normal temperature with only 300 ml. of blood in transit through the annular column. Since temperature control is an essential func- tion of cardiopulmonary bypass, both in normo- thermic and hypothermic perfusions, an appreci- able volume of priming blood is usually involved in heat exchange. This volume was eliminated by using the inner surface of the annulus for heat on September 24, 2021 by guest. Protected exchange. The efficiency of the bubble type of oxygenator is usually offset by the large volume of blood re- quired for debubbling by settling reservoirs after antifoaming. This volume was considerably reduced by efficient antifoaming, by low-pressure filtration, and by the use of a sump reservoir with an additional filter which together prevent vortex formation in the reservoir. 'Present adcdress: Department of Experimental Surgery, Hammer- smith Hospital, London, W.12 FIG. 1. Side view of oxygenator showirg stainless steel heat exchanger in vertical buibbling column. 540 Thorax: first published as 10.1136/thx.20.6.540 on 1 November 1965. Downloaded from A low priming volume oxygenator for bloodless priming in cardiopiulmonary bypass 541 - From water bath Heat Anti-foamed stainless steel wool Silastic valve .I. Detachable cartridge - ; 1-~ = Reservir Filter A ......Sump Recirculating tube .........-Filter 'B' FIG. 2. Diagram of oxygenator showing path offoam up the vertical annulus and into the horizontal defoaming copyright. cartridge. To arterial pump http://thorax.bmj.com/ on September 24, 2021 by guest. Protected FIG. 3. View of oxygenator showing valve control mechanism. The.far side valve is open into the far cartridge. Thorax: first published as 10.1136/thx.20.6.540 on 1 November 1965. Downloaded from 542 E. Proctor and A. H. De Bono SVE SILASTIC WASHER VALVE CLOSED VALVE OPEN GAS OUTLE.T FIG. 4. Diagram of twin cartridges from above showing path of foam from annulus into one of the defoaming cartridges. The valve mechanism allows only one cartridge to be used at a time and permits of the replacement of a used cartridge without stopping the blood flow by releasing the screw at the distal end of the cartridge. A theoretical disadvantage of bubble oxygen- As a result of these features the oxygenator hascopyright. ators has been the limited life of the antifoaming a priming volume of 500 ml. plus 250 ml. in the apparatus in extended perfusions. This problem arterial and venous lines, a total of 750 ml. This is has been overcome in two ways: (1) An improve- sufficient to initiate and maintain total bypass of ment in antifoaming properties and adhesion due up to 2-5 1./min. in dogs of 20 to 30 kg. The to baking 20°o Antifoam A on to the surface of system can therefore be primed with buffered scrupulously clean stainless steel wool at a electrolyte solutions (Ringer-Locke, Ringer- http://thorax.bmj.com/ temperature of 2000 C. for four to six hours. This Lactate), low molecular weight dextran, or com- gives a 'rubbery' texture to the silicone surface binations of these while maintaining full gas and improves both the antifoaming and adhesive exchange and adequate temperature control for qualities of the surface. The usual technique of normothermia, mild hypothermia, and slow dipping, drying, and autoclaving (McGregor, profound hypothermia. 1960) imparts a less adherent, greasy surface. It As an approximate guide to the degree of should be noted, however, that this improvement haemodilution involved, the average haematocrit is not sustained at higher temperatures, since at values for the usual one to two hours' total per- 3200 C. and above the silicone surface becomes fusion are: pre-bypass. 4400 ; during bypass, on September 24, 2021 by guest. Protected brittle and fragments with movement. The surface 330%; and 24 hours after bypass, 41 %. At no time resulting from baking at 2000 C. is sufficient for has it been necessary to add blood either during up to six hours' efficient antifoaming with the bypass or post-operatively. type of cartridge described. (2) By using twin anti- Although the oxygenator has so far been used foaming cartridges (Figs 3 and 4) which can be only for animal perfusions, a larger model switched alternately into the foam path, the anti- designed for flows of 4 to 5 1. /min. with an foaming time can be simply doubled to 12 hours. estimated priming volume of 12 to 1 5 1. Ringer- Should the need arise for extended perfusions Locke, etc., is in hand. beyond 12 hours as in long-term, partial, closed- chest perfusions for circulatory support the DESCRIPTION cartridges can be replaced without stopping the perfusion, thereby conferring an indefinite running The annulus for oxygenation and heat exchange is time limited only by the trauma to the blood. formed by the insertion of a thin-walled stainless steel Our experience in this field is as yet limited to tube into a vertical perspex tube. It is centralized and 10 hours. supported by the gas sinter at the bottom and a silastic Thorax: first published as 10.1136/thx.20.6.540 on 1 November 1965. Downloaded from A low priming volume oxygenator for bloodless priming in cardiopulmonary bypass 543 washer at the top. Sucker reservoir and venous lines Reservoir enter at the bottom of the tube. Length, 11-5 in. Width at upper end, 6 in. OXYGENATION Gas, usually 97 % oxygen and 3 % Width at sump, 2-5 in. carbon dioxide, enters through a sinter to give bubbles Depth, 2 5 in. of approximately 3 mm. diameter which foam and Volume, 1 litre. lift the blood up the annulus to a large port at the Sump top of the column where it is directed by the valves Depth, 4 in. into one of the antifoaming cartridges. With a ratio Internal diameter. 1-25 in. of 4 to 5 litres of gas flow per litre of blood flow the Filters oxygen saturations are 97 to 99% (arterial) and 70 to 80 gauge mesh stainless steel. 74% (venous) at flows up to 2 5 1./min. in 20-30 kg. Cartridges dogs at normothermia. Length, 11 in. HEAT EXCHANGE The stainless steel tube forms the Internal diameter, 2-5 in. inner surface of the annulus, and water from the Sinter appropriate water-bath emerges at the bottom via the 50 holes 0-021 in. diameter. narrow central tube and flows up between it and the inner surface. The efficiency of heat exchange METHOD OF USE obviously depends on a variety of factors-water flow, blood flow, temperature gradient, size of animal, etc. The reservoir is primed with 750 ml. of fluid, Ringer- -but with a dog weighing 20 kg., 2 1./min. blood Locke, Ringer-Lactate, or low molecular weight flow, and a water-bath temperature of 1-3° C. the dextran (Rheomacrodex5). The pH at 200 C. of temperature of the blood drops approximately 70 C. Ringer-Locke is 7-52; of Ringer-Lactate, 6-55; and in transit through the annulus in the range 200 C. of 10% low molecular weight dextran in dextrose, to 360 C. This will result in cooling the animal at 5x35 (mainly due to the dextrose). We normally use a 0.70 C./min. over the same range. Equally, a water- mixture of 550 ml. Ringer-Lactate and 200 ml. dextran. The pH of this mixture is 6-39 at 200 C. and bath temperature of 38.50 C. will maintain normo- copyright. thermia. 1 mEq of sodium bicarbonate converts this to 7-39. Since the liver is less able to metabolize lactate at ANTIFOAMING This occurs in the sloping cylindrical low temperatures, we tend to use Ringer-Locke in cartridges. The cylindrical shape allows of a good fit place of Ringer-Lactate for profound hypothermia. for the balls of stainless steel wool, a constant area of The arteriovenous loop is filled by attaching the silicone in contact with the blood, and no 'short-cuts' venous end of the loop to the re-circulating tube at for the foam. The rate of advance of the foam through the side of the reservoir and pumping the fluid http://thorax.bmj.com/ the cartridge is about 1 inch per hour. through the lines and back into the reservoir. The venous line is then connected to the bottom of the RESERVOIR The defoamed blood enters the reservoir bubbling tube. With the gas line, sucker reservoir line, at the distal end. This reservoir has a sloping floor and heat exchanger lines appropriately connected, the and is narrower at the lower end.
Load more

Recommended publications
  • 8 Implantable Membrane Oxygenator
    Artificial Lung 8 . Cardiopulmonary Bypass - oxgenator 1 Cardiopulmonary Bypass § Cardiopulmonary bypass (CPB), also called heart-lung bypass, allows the temporary replacement of the gas exchange function of the lungs and the blood-pumping function of the heart § The terms pump-oxygenator and heart–lung machine graphically describe the equipment used § By extension, the term is also applies to surgical procedures which take place primarily on the external aspects of the heart, such as creating new routes for blood to reach the distal coronary arteries from the aorta 3 Cardiopulmonary Bypass § As usually employed for cardiac surgery, the heart–lung machine is part of a total, venoarterial cardiopulmonary bypass circuit à meaning that all the venous blood returning to the right heart cavities is collected in the extracorporeal circuit à circulated through the gas exchange device, from where it is pumped back into the arterial tree à thereby “bypassing” the heart cavities and the pulmonary circulation 5 Cardiopulmonary Bypass Scheme of standard operating conditions during cardiopulmonary bypass 6 Cardiopulmonary Bypass 7 Artificial Lung Artificial Lung vs. Natural Lung 8 Artificial Lung vs. Natural Lung § In the natural lungs, the factors underlying exchange across the alveolo-capillary barrier and transport by the blood can be grouped into four classes:- ú The ventilation of the lungs (the volume flow rate of gas) and the composition of the gas mixture to which mixed venous (pulmonary artery) blood will be exposed 9 Artificial Lung vs. Natural Lung § In the natural lungs, the factors underlying exchange across the alveolo-capillary barrier and transport by the blood can be grouped into four classes:- ú The permeability of the materials which separate the gas phase from the blood phase in the pulmonary alveoli 10 Artificial Lung vs.
    [Show full text]
  • Left Atrial to Femoral Artery Full Cardiopulmonary Bypass: a Novel Technique for Descending and Thoracoabdominal Aortic Surgery
    Published online: 2019-12-09 Original Article 19 Left Atrial to Femoral Artery Full Cardiopulmonary Bypass: A Novel Technique for Descending and Thoracoabdominal Aortic Surgery Dimitra Papanikolaou, MD1 Chris Savio, BS, CCP1 Mohammad A. Zafar, MBBS1 Leon Freudzon, MD1 Jinlin Wu, MD1 Mohamed Abdelbaky, MD1 Keith J. Pelletier, MBA, MHS, CCP1 Joelle Buntin, MSN, RN, RN-BC1 Thais Faggion Vinholo, BS, MSc1 Bulat A. Ziganshin, MD, PhD1,2 Brian Schwartz, MS, CCP1 John A. Elefteriades, MD, PhD (Hon)1 1 Aortic Institute at Yale-New Haven Hospital, Yale University School Address for correspondence John A. Elefteriades, MD, Aortic Institute of Medicine, New Haven, Connecticut at Yale-New Haven, Yale University School of Medicine, Clinic Building 2 Department of Surgical Diseases, Kazan State Medical University, CB 317, 789 Howard Avenue, New Haven, CT 06519 Kazan, Russia (e-mail: [email protected]). Int J Angiol 2020;29:19–26. Abstract Left atrial-femoral artery (LA-FA) bypass with a centrifugal pump and no oxygenator is commonly used for descending and thoracoabdominal aortic (DTAA) operations, mitigating the deleterious effects of cross-clamping. We present our initial experience performing DTAA replacement under LA-FA (left-to-left) cardiopulmonary bypass (CPB) with an oxygenator. DTAA replacement under LA-FA bypass with an oxygenator was performed in 14 consecutive patients (CPB group). The pulmonary vein and femoral artery (or distal aorta) were cannulated and the full CPB machine were used, including oxygenator, roller pump, pump suckers, and kinetically enhanced drainage. The CPB group was compared with 50 consecutive patients who underwent DTAA replacement utilizing traditional LA-FA bypass without an oxygenator (LA-FA group).
    [Show full text]
  • The Mayo Gibbon Heart-Lung Bypass Machine in the Marc
    Mayo Clinic Proceedings Legacy December 2014 Pioneers in Cardiac Surgery: The Mayo Gibbon Heart-Lung Bypass Machine This preliminary report shared the results from animal studies, but by May of that same year, Mayo Clinic had initiated use of the apparatus for human subjects and reported on the outcome in 8 cases.2 These patients had the following conditions: (1) ventricular septal defect, (2) Tetralogy of Fallot, or (3) persistent common atrioventricular canal. Four of the patients survived the surgery, one died shortly after the procedure, two died 3 hours postoperatively, and one died 6 days postoperatively.2 Mayo Clinic continued to study and develop successful surgical treatments in cardiology throughout the ensuing years. More than 60 years have passed since these first attempts, and success in cardiac surgery is directly related to these courageous research pioneers and patients. 1,2,3 This historical line of research in In the March 13, 1955, issue of The Proceedings cardiology also represents another successful of the Staff Meetings of the Mayo Clinic, Dr collaboration between the field of medicine John W. Kirklin and colleagues shared a and industry. International Business Machines preliminary report of their research from the (IBM) aided in the design and development of previous 3 years which tackled the challenges the Mayo Gibbon Heart-Lung Bypass of cardiac surgery. While other types of Machine.1,2,3 surgeries have their own impediments, cardiac surgery is dominated by the need to keep a References patient alive during the procedure while 1. Jones RE, Donald DE, Swan HJ, Harshbarger HG, maintaining the function of the circulatory Kirklin JW, Wood EH.
    [Show full text]
  • Principles of Oxygenator Function: Gas Exchange, Heat Transfer, and Operation
    Thoracic Key Fastest Thoracic Insight Engine Home Log In Register Categories » More References » About Gold Membership Contact Search... Principles of Oxygenator Function: Gas Exchange, Heat Transfer, and Operation Principles of Oxygenator Function: Gas Exchange, Heat Transfer, and Operation Michael H. Hines INTRODUCTION Since the early 1950s when the development of a heart-lung machine first began, there has been a tremendous evolution of devices and machinery for cardiac support (1,2). However, despite the diversity in designs through the years, they all contain three essential components: a mechanism to circulate the blood, a method of gas exchange for oxygen and carbon dioxide, and some mechanism for temperature control. Chapter 2 has covered the first important component, and we will now focus on the two subsequent elements: gas exchange and heat transfer. And while it is referred to as the “oxygenator,” we must recognize that it is responsible for the movement of both oxygen in, as well as carbon dioxide out. The discussion will start with a basic review of the principles of physics, and then we will apply those principles to the devices used specifically in extracorporeal support, including cardiopulmonary bypass (CPB) and extracorporeal membrane oxygenation (ECMO). You may notice as you go through this chapter that there is a scarcity of trade and manufacturer names. The author has intentionally avoided using these. The intent was primarily to focus on the physiology, physics, and chemistry of the oxygenator and heat exchanger, but also to emphasize the fact that there are a large number of manufacturers producing many products that have all been shown to function extremely well.
    [Show full text]
  • ECMO (Extracorporeal Membrane Oxygenation)
    ECMO (Extracorporeal Membrane Oxygenation) ECMO stands for Extracorporeal Membrane Oxygenation. It is a type of life support that uses a machine to pump blood rich in oxygen to support the heart or lungs, or both. The ECMO machine acts as an artificial heart and lung for a patient whose own heart or lungs cannot provide enough blood flow or get enough oxygen into the blood. ECMO is used after other methods of supporting the heart and lungs did not work. Once a patient is on ECMO, you may see an improvement because their heart and lungs may "rest" while ECMO takes over. The goal of ECMO is to let the heart and lungs recover while the patient is supported by the ECMO machine. Tests before Using ECMO Some heart defects can cause symptoms that seem at first to be a lung problem. So, before Carotid arteries using ECMO, doctors do tests to see if the Jugular veins cause of the problem is the heart or the Aorta Right atrium Pulmonary (lung) lungs. It is important to know if the heart artery is working well or not. Capillaries These tests are done before ECMO is started and sometimes at other times during the Pulmonary ECMO course: veins . Echocardiogram ("heart echo") uses Heart sound waves to look at the heart’s structure and function. See Helping Hand HH-III-114, Echocardiogram: Lungs Sedated. Picture 1 The normal heart-lung system. Blood is . Electrocardiogram (EKG) is a test pumped from the heart to the capillaries in the lungs. that looks at the heart's electrical system.
    [Show full text]
  • Directions for Use Tandemlung Oxygenator CAT# 5160-0000
    Directions for Use TandemLung Oxygenator CAT# 5160-0000 7000-0161 Rev.7 2018-08-23 Page | 2 Figure 1. TandemLung Oxygenator Page | 3 1. Overview The TandemLung Oxygenator is used in cardiac surgery, in combination with a blood pump to oxygenate blood and remove carbon dioxide. The device consists of a hollow fiber membrane with blood inflow and outflow port and gas inlet and outlet port. Blood enters into the center of the fiber bundle where it is distributed radially and uniformly across the fiber bundle by a conical diffuser. The compact nature of the device, the orientation of the inflow/outflow ports, and optimized gap sizes on the inlet and outlet of the bundle simplify the priming process. 2. Indications for Use The TandemLung Oxygenator (TLO) is intended to be used for adult patients for extracorporeal circulation during cardiopulmonary bypass in the field of open-heart surgery. Within the indicated flow rates blood is oxygenated and carbon dioxide is removed. The utilization period of this device is restricted to six hours. 3. Contraindications No contraindications are known provided the device is used within the Indications for Use and in accordance with the stated operating conditions. 4. Warnings and Precautions Only use the device in accordance with these Instructions for Use. • The oxygenator may only be used by persons trained in extracorporeal circulation procedures. • Possible side effects include infections, hemolysis, and embolisms. Side effects associated with extracorporeal circulation in general may also occur (e.g., post- perfusion syndrome and organ damage). • Observe the use-by date on the device packaging.
    [Show full text]
  • Cardiopulmonary Bypass Heart-Lung Machine Console
    Food and Drug Administration, HHS § 870.4290 § 870.4220 Cardiopulmonary bypass or pieces of foreign material flowing in heart-lung machine console. the bloodstream which will obstruct (a) Identification. A cardiopulmonary circulation by blocking a vessel) out of bypass heart-lung machine console is a the blood. It is used in the arterial re- device that consists of a control panel turn line. and the electrical power and control (b) Classification. Class II (special circuitry for a heart-lung machine. The controls). The special control for this console is designed to interface with device is the FDA guidance document the basic units used in a gas exchange entitled ‘‘Guidance for system, including the pumps, Cardiopulmonary Bypass Arterial Line oxygenator, and heat exchanger. Blood Filter 510(k) Submissions.’’ (b) Classification. Class II (perform- ance standards). [45 FR 7907–7971, Feb. 5, 1980, as amended at 52 FR 17737, May 11, 1987; 66 FR 18542, Apr. 10, § 870.4230 Cardiopulmonary bypass 2001] defoamer. (a) Identification. A cardiopulmonary § 870.4270 Cardiopulmonary bypass bypass defoamer is a device used in cardiotomy suction line blood filter. conjunction with an oxygenator during (a) Identification. A cardiopulmonary cardiopulmonary bypass surgery to re- bypass cardiotomy suction line blood move gas bubbles from the blood. filter is a device used as part of a gas (b) Classification. Class II (special exchange (oxygenator) system to filter controls). The special control for this nonbiologic particles and emboli (a device is the FDA guidance document blood clot or a piece of foreign mate- entitled ‘‘Guidance for Extracorporeal rial flowing in the bloodstream which Blood Circuit Defoamer 510(k) Submis- will obstruct circulation by blocking a sions.’’ vessel) out of the blood.
    [Show full text]
  • An Improved Technique for Isolated Perfusion of Rat Livers and an Evaluation of Perfusates HANS J
    JOUHNAL OF SURGICAL RESEARCH 53, 158-165 (1992) An Improved Technique for Isolated Perfusion of Rat Livers and an Evaluation of Perfusates HANS J. MISCHINGER, M.D.,t THOMAS R. WALSH, M.D.,2 TAO Lm, M.D., PRAKASH N. RAO, PH.D., RANDY RUBIN, B.S., KENJIRO NAKAMURA, M.D., SATORU TODO, M.D., AND THOMAS E. STARZL, M.D., PH.D.3 Department of SurRery, University of PittsburRh, School of Medicine. Pittsburgh. Pennsylvania 15213 Submitted for publication April 27, 1990 ity of investigators have used variations of the original We have modified the apparatus for isolated rat liver perfusion arrangement introduced by Brower and Miller perfusion (IPRL) in order to be able to perform two [1-6]. At our laboratories this organ perfusion technique perfusions simultaneously. In addition, we studied the is performed to assess the viability of preserved livers quality and stability of livers by comparison of five dif­ prior to transplantation. ferent perfusates: Blood (Group A), Original Krebs To enable us to perfuse livers more efficiently, we con­ Henseleit buffer (Group B), Krebs buffer with glucose structed an IPRL apparatus designed to perfuse two (Group C) or bovine serum albumin (BSA) added, livers simultaneously. This perfusion arrangement al­ (Group D). In a last group (E) albumin, glucose, and lows more studies to be performed in less time and simul­ taurocholic acid were added to Krebs. After 180 min of taneous comparisons of different treatment regimens. perfusion, livers perfused with solutions including 2% This manuscript concerns the practical aspects of this albumin (Group D, E) had a significantly higher release of hepatocellular and endothelial cell (purine nucleo­ model as well as a study which compares stability of side phosphorylase) enzymes and lower bile production livers during perfusions with homologous blood, and as compared to Groups A, B, and C (P < 0.0001).
    [Show full text]
  • Physiological Basis of Extracorporeal Membrane Oxygenation and Extracorporeal Carbon Dioxide Removal in Respiratory Failure
    membranes Review Physiological Basis of Extracorporeal Membrane Oxygenation and Extracorporeal Carbon Dioxide Removal in Respiratory Failure Barbara Ficial 1, Francesco Vasques 1, Joe Zhang 1, Stephen Whebell 1 , Michael Slattery 1, Tomas Lamas 2 , Kathleen Daly 1, Nicola Agnew 1 and Luigi Camporota 1,3,* 1 Department of Adult Critical Care, Guy’s and St. Thomas’ NHS Foundation Trust, King’s Health Partners, London SE1 7EH, UK; barbara.fi[email protected] (B.F.); [email protected] (F.V.); [email protected] (J.Z.); [email protected] (S.W.); [email protected] (M.S.); [email protected] (K.D.); [email protected] (N.A.) 2 Department of Critical Care, Unidade de Cuidados Intensivos Polivalente, Egas Moniz Hospital, Rua da Junqueira 126, 1300-019 Lisbon, Portugal; [email protected] 3 Division of Centre of Human Applied Physiological Sciences, King’s College London, London SE1 7EH, UK * Correspondence: [email protected] Abstract: Extracorporeal life support (ECLS) for severe respiratory failure has seen an exponential growth in recent years. Extracorporeal membrane oxygenation (ECMO) and extracorporeal CO2 removal (ECCO2R) represent two modalities that can provide full or partial support of the native lung function, when mechanical ventilation is either unable to achieve sufficient gas exchange to meet metabolic demands, or when its intensity is considered injurious. While the use of ECMO has Citation: Ficial, B.; Vasques, F.; defined indications in clinical practice, ECCO2R remains a promising technique, whose safety and Zhang, J.; Whebell, S.; Slattery, M.; efficacy are still being investigated. Understanding the physiological principles of gas exchange Lamas, T.; Daly, K.; Agnew, N.; during respiratory ECLS and the interactions with native gas exchange and haemodynamics are Camporota, L.
    [Show full text]
  • An Introduction to Extracorporal Circulation During Open Heart Surgery
    An introduction to extracorporal circulation during open heart surgery 1. Introduction During open heart surgery, the surgical intervention is typically performed on a non-beating heart, and hence requires establishment of extracorporal circulation (ECC). During ECC, a heart-lung-machine temporarily replaces the functionality of the heart and lungs. This technique is therefore also called cardio pulmonary bypass (CPB). During closed heart surgery, the incision is performed without use of a heart-lung-machine. Coronary bypass operations can therefore in a number of cases be performed on a beating heart without use of ECC. The method is called OPCAP (Off Pump Coronary Artery Bypass). 2. The Primary Extra Corporal circuit During ECC the blood from the right side of the heart is drained through a venous catheter to a venous reservoir. Following this, the blood is pumped to an artificial lung – the oxygenator – where oxygen is added and carbondioxide is washed out. Finally the blood is pumped back into the systemic circulation by an arterial canulla in aorta ascendens. The oxygenator has a built-in heat-exchange system, which gives the blood the desired temperature. The individual components in the primary extracorporal circuit are described below from veneous catheter to arterial canulla. Figure 1. The primary extra corporal circuit. The right side of the heart is drained through a venous catheter to a venous reservoir. Following this, the blood is pumped to an artificial lung – the oxygenator – where oxygen is added and carbon dioxide is washed out. The oxygenated blood is pumped back into the systemic circulation through an arterial filter and by an arterial canulla in aorta ascendens.
    [Show full text]
  • Guidance for Cardiopulmonary Bypass Oxygenators 510(K) Submissions; Final Guidance for Industry and FDA Staff
    Guidance for Cardiopulmonary Bypass Oxygenators 510(k) Submissions; Final Guidance for Industry and FDA Staff Document issued on: November 13, 2000 This document supersedes Guidance for Cardiopulmonary Bypass Oxygenators 510(k) Submissions; Final January 17, 2000 U.S. Department of Health and Human Services Food and Drug Administration Center for Devices and Radiological Health Circulatory Support and Prosthetic Devices Branch Division of Cardiovascular and Respiratory Devices Office of Device Evaluation Preface Public Comment: Comments and suggestions may be submitted at any time for Agency consideration to Dockets Management Branch, Division of Management Systems and Policy, Office of Human Resources and Management Services, Food and Drug Administration, 5630 Fishers Lane, Room 1061, (HFA-305), Rockville, MD, 20852. When submitting comments, please refer to the exact title of this guidance document. Comments may not be acted upon by the Agency until the document is next revised or updated. For questions regarding the use or interpretation of this guidance contact Catherine Wentz at (240) 276-4141 or by e-mail at [email protected]. Additional Copies: Additional copies are available from the Internet at: http://www.fda.gov/cdrh/ode/guidance/1361.pdf or CDRH Facts-on-Demand. In order to receive this document via your fax machine, call the CDRH Facts-On-Demand system at 800-899-0381 or 301-827-0111 from a touch-tone telephone. Press 1 to enter the system. At the second voice prompt, press 1 to order a document. Enter the document number 1361 followed by the pound sign (#). Follow the remaining voice prompts to complete your request.
    [Show full text]
  • A History of Innovation: Cardiac Surgery in Minnesota
    RETROSPECTIVE A LOOK BACK AT MEDICINE A History of Innovation CARDIAC SURGERY IN MINNESOTA COURTESYPHOTO OF MINNESOTA UNIVERSITY ABOVE: C. Walton BY JOHNATHON M. AHO, MD, MATTHEW S. SCHAFF, MD, CORNELIUS A. THIELS, DO, MBA, ROBERT A. DARLING, MD, Lillehei and team MARK N. PRICE KOERNER AND HARTZELL V. SCHAFF, MD performing a controlled cross-circulation For centuries, the heart was believed to be an inoperable organ. Through the development of new technologies operation in the mid-1950s. and techniques, the initial difficulties inherent with operating on a moving organ began to fade. But as surgeons in the last century pushed the boundaries of cardiac repair, new problems arose. To solve them, they enlisted the help of physiologists, residents and engineers. By taking a multidisciplinary approach, sharing information and ideas, and working collaboratively, University of Minnesota and Mayo Clinic investigators found themselves at the forefront of cardiac surgery. This article reviews Minnesota’s contributions to the field. “There, for a shining moment, the THE EARLY YEARS ment of shrapnel.6 The early successes of only institutions where one could As surgery involving other organs ad- Harken and other combat surgeons as well as vanced, Aristotle’s conviction that the the development of extracardiac procedures go for open heart surgery were heart was inoperable prevailed and most such as closure of the patent ductus arterio- 90 miles apart, at the Mayo Clinic surgeons viewed operating on the heart as sus in 1939, repair of an aortic coarctation and the University of Minnesota.” taboo.3 That thinking was challenged to in 1945 and development of the Blalock- some extent in the early 19th century with Taussig shunt for treating cyanotic heart — Norman Shumway, MD the development of extracardiac procedures disease in the 1940s convinced surgeons that for treating penetrating thoracic injuries.
    [Show full text]